Fundraising Fox

Access Vascular

Bedford, US · Founded 2015 · Delaware corporation · 2 known investors

Develops venous access devices made from patented biocompatible biomaterials designed to reduce infections, thrombosis, and phlebitis in intravenous therapy.

Biotechin /access-vascular-inc-

Founders & leadership

PS
Paul SabinDirector
JP
Joseph PellegrinoDirector
JB
James BigginsExecutive Officer, Director
BR
Brent RatzDirector

Investors · 2

Green Park & Golf VenturesDallas · $500K – $2M
TVM CapitalMunich · $1.1M – $16.2Mvia Luc Marengere · board

Reported raises · per SEC filings

Form D private placements
▶$20.6MraisedOct 2023 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JJ PelligrinoDirector
  • Amine BentalebDirector
  • James BigginsExecutive Officer
  • Luc MarengereDirector
  • Michael R JaffDirector
  • Marc RiviereDirector
  • Brent SabinDirector
Offering amount
$31.6M
Amount sold
$20.6M
Minimum investment
$8K
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MofferedOct 2022 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Luc MarengereDirector
  • Brent SabinDirector
  • James BigginsExecutive Officer
  • JJ PelligrinoDirector
  • Michael R JaffDirector
  • Marc RiviereDirector
  • Amine BentalebDirector
Offering amount
$10M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.9MraisedMar 2021 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JJ PelligrinoDirector
  • Paul SabinDirector
  • Brent RatzDirector
  • James BigginsExecutive Officer
  • Michael R JaffDirector
  • Amine BentalebDirector
  • Luc MarengereDirector
  • Alexandra MacLeanDirector
Offering amount
$19.9M
Amount sold
$19.9M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.6MraisedSep 2019 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul SabinDirector
  • James BigginsExecutive Officer
  • JJ PelligrinoDirector
  • Brent RatzDirector
Offering amount
$7.3M
Amount sold
$5.6M
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedMay 2018 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brent RatzDirector
  • Paul SabinDirector
  • Joseph PellegrinoDirector
  • James BigginsExecutive Officer, Director
Offering amount
$4M
Amount sold
$1.9M
Minimum investment
$25K
First sale
May 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedAug 2017 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul SabinDirector
  • Joseph PellegrinoDirector
  • James BigginsExecutive Officer, Director
  • Brent RatzDirector
Offering amount
$3.8M
Amount sold
$3.8M
Minimum investment
$15K
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.